Cerity Partners LLC Sells 3,523 Shares of Integer Holdings Corporation (NYSE:ITGR)

Cerity Partners LLC reduced its stake in Integer Holdings Corporation (NYSE:ITGR) by 11.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,658 shares of the medical equipment provider’s stock after selling 3,523 shares during the period. Cerity Partners LLC owned approximately 0.08% of Integer worth $3,264,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Capital Research Global Investors lifted its position in Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock valued at $186,960,000 after acquiring an additional 194,895 shares in the last quarter. Loomis Sayles & Co. L P raised its stake in shares of Integer by 3.8% in the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider’s stock worth $74,041,000 after purchasing an additional 20,688 shares during the last quarter. Congress Asset Management Co. lifted its holdings in shares of Integer by 4.9% during the first quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider’s stock valued at $61,679,000 after purchasing an additional 24,306 shares in the last quarter. Driehaus Capital Management LLC boosted its position in shares of Integer by 5.5% during the fourth quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider’s stock valued at $59,828,000 after buying an additional 23,706 shares during the last quarter. Finally, Northern Trust Corp boosted its position in shares of Integer by 14.2% during the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock valued at $55,974,000 after buying an additional 52,556 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and raised their price target for the company from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James Financial increased their price target on Integer from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, April 25th. Wall Street Zen raised Integer from a “sell” rating to a “hold” rating in a report on Monday, May 19th. KeyCorp reduced their price objective on Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Finally, Benchmark dropped their target price on Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a research report on Friday, April 25th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $146.25.

Insider Transactions at Integer

In other Integer news, Director Donald J. Spence sold 14,739 shares of the firm’s stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the sale, the director directly owned 18,781 shares of the company’s stock, valued at $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the business’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares in the company, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock valued at $44,577,115 over the last three months. Corporate insiders own 2.16% of the company’s stock.

Integer Stock Performance

NYSE:ITGR opened at $112.51 on Friday. The stock has a 50-day simple moving average of $119.65 and a two-hundred day simple moving average of $124.45. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The firm has a market capitalization of $3.93 billion, a PE ratio of 53.32, a P/E/G ratio of 0.99 and a beta of 0.98.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Integer had a return on equity of 11.95% and a net margin of 4.38%. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same period in the previous year, the company posted $1.14 EPS. The firm’s revenue was up 7.3% on a year-over-year basis. Analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.